Pay in 4 interest-free payments of $7.34 Learn more
Ships within 48 hours · Estimated delivery Oct 31 - Nov 5
Common Plateau Periods: Weeks 8-12: Dose escalation catches up to side effects Weeks 28-32: Metabolic adaptation to reduced body weight Weeks 44-52: Approaching biological set point What to Do: Continue medicationplateaus typically resolve within 3-4 weeks Increase protein intake (preserve muscle mass) Add or intensify resistance training Ensure adequate sleep (affects weight loss hormones) Consider brief diet break (reverse metabolic adaptation) What NOT to Do: Don't increase dose without medical guidance Don't dramatically cut calories further (counterproductive) Don't stop medication during plateau Don't compare your week 20 to someone else's week 40 The Discontinuation Decision TRIUMPH-4 showed 18.2% discontinuation rate at 12mg dose
Drivers of Growth in GLP-1 Nutritional Support The demand for GLP-1 nutritional support is fueled by the increasing prevalence of obesity and type 2 diabetes, which affects over 30% of the global population
The initial weeks often involve gradual dose increases, allowing time to monitor how the body responds
They represent thousands of people watching their hair thin while pursuing a healthier weight, caught between the undeniable benefits of weight loss therapy and an unexpected cosmetic consequence that nobody prepared them for
Semaglutide, like Tirzepatide, was initially conceived as a treatment for type 2 diabetes
.jpg)